FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/09/027986 [Registered on: 23/09/2020] Trial Registered Prospectively
Last Modified On: 01/03/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   ultrasound image collection 
Study Design  Other 
Public Title of Study   Collection of ultrasound images in early pregnancy and in women with a prescription for pelvic scan to build a software that will help the sonologist analyze automatically normal or abnormal ultrasound images in the early first trimester of pregnancy. 
Scientific Title of Study   Prospective ultrasound data collection of normal and abnormal obstetric and gynecological cases to develop an artificial intelligence algorithm 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
ICBE-S-000017  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Devika Gunasheela 
Designation  Managing partner 
Affiliation  Gunasheela Surgical & Maternity Hospital 
Address  Gunasheela Surgical & Maternity Hospital Gunasheela IVF Centre, No. 1, Dewan Madhava Rao Road, Opp. M. N. Krishna Rao Park, Basavanagudi, Bangalore - 560004, India

Bangalore
KARNATAKA
560004
India 
Phone  9964099475  
Fax    
Email  gunasheelaivf@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Pallavi Vajinepalli 
Designation  Principal scientist and team leader 
Affiliation  Philips India Ltd 
Address  Philips Innovation Campus Manyata Tech Park, Nagavara, Bangalore – 560045, India

Bangalore
KARNATAKA
560045
India 
Phone  9986375873  
Fax    
Email  pallavi.vajinepalli@philips.com  
 
Details of Contact Person
Public Query
 
Name  Pallavi Vajinepalli 
Designation  Principal scientist and team leader 
Affiliation  Philips India Ltd 
Address  Philips Innovation Campus Manyata Tech Park, Nagavara, Bangalore – 560045, India


KARNATAKA
560045
India 
Phone  9986375873  
Fax    
Email  pallavi.vajinepalli@philips.com  
 
Source of Monetary or Material Support  
Philips India Ltd 
 
Primary Sponsor  
Name  Philips India Ltd 
Address  Philips India Ltd, Philips Research Bangalore India, Philips Innovation Campus Manyata Tech Park, Nagavara, Bangalore – 560045, India  
Type of Sponsor  Other [medical device company] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Devika Gunasheela  Gunasheela Surgical & Maternity Hospital Gunasheela IVF Centre,  Gunasheela Surgical & Maternity Hospital Gunasheela IVF Centre, No. 1, Dewan Madhava Rao Road, Opp. M. N. Krishna Rao Park, Basavanagudi, Bangalore - 560004, India
Bangalore
KARNATAKA 
9964099475

gunasheelaivf@gmail.com 
Dr Nitin G Chaubal  Thane ultrasound centre  Thane ultrasound centre, Shanti Niwas Dr Moose Road Talaopali Thane W, Thane, Maharashtra – 400601, India
Thane
MAHARASHTRA 
9619072238

thaneultrasound@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Independent Ethics Committee IEC@IISS  Approved 
Institutional Ethics Committee (IEC)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  • Female patients, aged 18 years or more, presenting for a routine or referred obstetric or a gynaecological ultrasound scan 
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  Inclusion criteria for subject selection
1.Female patients, aged 18 years or more, presenting for a routine or referred obstetric or a gynaecological ultrasound scan
2.For obstetric cases only:
a.An ultrasound gestational age between 5 to 10 weeks and 6 days of gestation for normal pregnancies
b.A gestational age inferior to 14 weeks for abnormal pregnancies (ectopic pregnancy, blighted ovum and other types of pregnancy loss, hydatiform mole, etc.)
c.Singleton pregnancy or multiple pregnancy
d.Normal pregnancy or abnormal pregnancy (abnormal early first trimester conditions such as ectopic pregnancy, blighted ovum and other types of pregnancy loss, hydatiform mole, etc.)
3.For gynaecologic cases only:
Subject presenting with a normal or abnormal pelvic scan
4.Subject willing and able to provide informed consent 
 
ExclusionCriteria 
Details  1.Subject aged below 18 years.
2.For obstetric cases only:
a.Subject with a pregnancy younger than 5 and equal or older than 11 weeks for normal pregnancies.
b.Subject with a pregnancy superior to 14 weeks for abnormal pregnancies.
3.Subject presenting with fever or hemorrhagia or any condition that needs emergency care (as per investigator’s discretion).
4.Subject with neurological or psychiatric disorders or other disorders that affect the subject’s understanding of the information provided with the consent form.
5.IIliterate subjets and subjects unwilling or unable to provide informed consent.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
This is a data collection study, there are no specific primary clinical outcome other than collecting the ultrasound data as per the clinical
Protocol. The primary endpoint of the study will be reached when
125 subjects with data validated by the Sponsor have been enrolled at each site.
 
31st May 2021 
 
Secondary Outcome  
Outcome  TimePoints 
NA  NA 
 
Target Sample Size   Total Sample Size="250"
Sample Size from India="250" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/09/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not planned yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is a prospective data collection study.

The main objective of the study is to collect 2D, M-mode and 3D ultrasound imaging in the early first trimester pregnancies (5 weeks to 10 weeks and 6 days) and in gynaecological subjects to check the feasibility of automated detection and quantification in early normal and abnormal pregnancies. In order to build clinically useful algorithms, the data should represent a variety of situations that is found in current practice; the dataset should hence contained at least the following:

·      First trimester pregnancies (normal and abnormal such as ectopic pregnancies)

·      Surrounding anatomical structures (such as ovaries, Fallopian tubes and Douglas cul-de-sac)

·      Imaging data with features that can be confused with early pregnancy (such as normal and abnormal uterine findings in non-pregnant women)

·      Images acquired with different ultrasound modes: standard 2D view, M-mode (fetal heart rate), 3D.

The data collection study will be performed at Gunasheela Surgical and Maternity Hospital, Gunasheela IVF centre, Bangalore (site 1) and Thane Ultrasound centre, Mumbai (site 2), both are referral centres in India.

De-identified 2D, 3D ultrasound images and videos of 250 women presenting with: normal first trimester pregnancies (180), abnormal first trimester pregnancies (30), normal (20) or abnormal (20) pelvic scan will be shared with the sponsor (125 subjects total per site).

Data collection will be done on the commercial registered ultrasound devices of the centres (Philips Affiniti 50/70, Philips Epiq 5/7) and on a commercially released ultrasound device from the sponsor (ClearVue 650/850). All devices will be used within their intended use.

Study will be registered in the CTRI website as per local regulations (India).

The variety and number of data/image sets needed to build accurate machine learning algorithms is high and an amendment will be proposed if the data sets do not meet the researchers’ requirement to build accurate algorithms as decided by the researchers or after review of algorithms’ results by clinicians/KOLs (interviews/focus group, etc… 
Close